Volume 44, Issue 1, Pages (January 2006)

Slides:



Advertisements
Similar presentations
EASL Clinical Practice Guidelines: Vascular diseases of the liver Journal of Hepatology Volume 64, Issue 1, Pages (January 2016) DOI: /j.jhep
Advertisements

Omega 3 – Omega 6: What is right for the liver? Ashraf Mohammad El-Badry, Rolf Graf, Pierre-Alain Clavien Journal of Hepatology Volume 47, Issue 5, Pages.
Global gene repression in hepatocellular carcinoma and fetal liver, and suppression of dudulin-2 mRNA as a possible marker for the cirrhosis-to-tumor transition.
Volume 61, Issue 2, Pages (August 2014)
Volume 63, Issue 1, Pages (July 2015)
Volume 46, Issue 3, Pages (March 2007)
Kirsten Boonstra, Ulrich Beuers, Cyriel Y. Ponsioen 
Inflammasomes in liver diseases
Volume 67, Issue 5, Pages (November 2017)
Volume 50, Issue 4, Pages (April 2009)
MELD: the holy grail of organ allocation?
Natural history and prognostic indicators of survival in cirrhosis: A systematic review of 118 studies  Gennaro D'Amico, Guadalupe Garcia-Tsao, Luigi.
Lifestyle interventions for the treatment of non-alcoholic fatty liver disease in adults: A systematic review  Christian Thoma, Christopher P. Day, Michael.
MELD score is a better prognostic model than Child-Turcotte-Pugh score or Discriminant Function score in patients with alcoholic hepatitis  Wichit Srikureja,
High-Throughput Homogeneous Mass Cleave Assay Technology for the Diagnosis of Autosomal Recessive Parkinson's Disease  Christopher Schroeder, Michael.
Novel insights in the interplay between inflammation and metabolic diseases: A role for the pathogen sensing kinase PKR  Nicolas Marsollier, Pascal Ferré,
Volume 42, Issue 6, Pages (June 2005)
Halis Simsek, Ali Shorbagi, Yasemin Balaban, Gonca Tatar 
Reactive oxygen species in the normal and acutely injured liver
Matthew T. Kitson, Stuart K. Roberts  Journal of Hepatology 
Volume 64, Issue 6, Pages (June 2016)
NS5A inhibitors in the treatment of hepatitis C
Immigration and viral hepatitis
Detection of two Alu insertions in the CFTR gene
Cystic fibrosis: A new mutation in the Lebanese population
Volume 66, Issue 1, Pages 1-4 (January 2017)
Living donor liver transplantation: is the hype over?
David G. Bowen, Christopher M. Walker  Journal of Hepatology 
Volume 42, Issue 4, Pages (April 2005)
Reply to: “DCD consensus and futility in liver transplantation”
Natural history and predictors of severity of chronic hepatitis C virus (HCV) and human immunodeficiency virus (HIV) co-infection  Anaïs Vallet-Pichard,
Hepatitis C core protein – The “core” of immune deception?
Volume 64, Issue 6, Pages (June 2016)
Burcin Ekser, Eric Lagasse  Journal of Hepatology 
Marc van der Valk, Hans L. Zaaijer, Arnon P. Kater, Janke Schinkel 
Volume 44, Issue 1, Pages (January 2006)
Volume 70, Issue 1, Pages (January 2019)
Statin use and the risk of hepatocellular carcinoma in patients at high risk: A nationwide nested case-control study  Gyuri Kim, Suk-Yong Jang, Chung.
Volume 57, Issue 2, Pages (August 2012)
Volume 62, Issue 3, Pages (March 2015)
DNA-Based Diagnosis of Xeroderma Pigmentosum Group C by Whole-Genome Scan Using Single-Nucleotide Polymorphism Microarray  Ching-Wan Lam, Kitty Kit-Ting.
Volume 62, Issue 1, Pages (January 2015)
EASL Clinical Practice Guidelines: Wilson’s disease
Volume 61, Issue 6, Pages (December 2014)
Roberto de Franchis, Aleksander Krag  Journal of Hepatology 
Volume 44, Issue 2, Pages (February 2006)
Volume 41, Issue 4, Pages (October 2004)
Volume 57, Issue 5, Pages (November 2012)
Hepatology may have problems with putative surrogate outcome measures
Volume 50, Issue 4, Pages (April 2009)
Antiviral therapy for chronic hepatitis B: Challenges in Hong Kong
Immigration and viral hepatitis
Clinical Practice Guidelines of the European Association for the study of the Liver – Advancing methodology but preserving practicability  Markus Cornberg,
HCV targeting of patients with cirrhosis
The impact of intestinal microflora on serum bilirubin levels
Volume 63, Issue 1, Pages (July 2015)
Familial amyloidosis: Great progress for an orphan disease
Volume 66, Issue 3, Pages (March 2017)
Volume 62, Issue 3, Pages (March 2015)
Liver transplantation in children
Pathogenesis of cholestatic hepatitis C
Genetic alterations in advanced HBV-related HCC with portal vein tumor thrombosis: Insights from next generation DNA sequencing  Roongruedee Chaiteerakij,
Chimeric mouse model of hepatitis B virus infection
Identification of Recurrent Mutations in the ARS (Component B) Gene Encoding SLURP-1 in Two Families with Mal de Meleda  Kimberley Morine Ward, Jülide.
Volume 50, Issue 1, Pages 4-6 (January 2009)
Genetics of hepatocellular carcinoma: The next generation
Volume 70, Issue 5, Pages (May 2019)
MELD: the holy grail of organ allocation?
Fondaparinux (Arixtra∗) hepatotoxicity in a 6 year-old child
Volume 53, Issue 4, Pages (October 2010)
Presentation transcript:

Volume 44, Issue 1, Pages 240-242 (January 2006) A patient with novel ABCB11 gene mutations with phenotypic transition between BRIC2 and PFIC2  Ching-Wan Lam, Ka-Ming Cheung, Man-Shan Tsui, Matthew Shu-Ching Yan, Ching-Yin Lee, Sui-Fan Tong  Journal of Hepatology  Volume 44, Issue 1, Pages 240-242 (January 2006) DOI: 10.1016/j.jhep.2005.09.013 Copyright © 2005 European Association for the Study of the Liver Terms and Conditions

Fig. 1 Mutational analysis. (Top) The missense mutation 1493 T>C or I498T in the patient shown in the sense direction. (Middle) The SNP 1605C>T or A535A in the patient is shown in the sense direction. (Bottom) The deletion of an adenine at the nucleotide position 2098 in the patient. The pattern is an overlap of sense strands of the wild type sequence (5′-CAACGCTCCAAGTCTCAGCTTTC-3′) and the mutant sequence (5′-CAACGCTCCAGTCTCAGCTTTC-3′). Heterozygous sites are denoted by the letter N. [This figure appears in colour on the web.] Journal of Hepatology 2006 44, 240-242DOI: (10.1016/j.jhep.2005.09.013) Copyright © 2005 European Association for the Study of the Liver Terms and Conditions